Page last updated: 2024-08-25

rosiglitazone and Brain Inflammation

rosiglitazone has been researched along with Brain Inflammation in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bendayan, R; Choi, UY; Hoque, MT; Omeragic, A1
Ballesteros, I; Corbí, ÁL; Cuartero, MI; Hamilton, JA; Lizasoain, I; Moraga, A; Moro, MA; Nombela, F; Vivancos, J1
Carta, AR; Casu, MA; Diana, A; Lecca, D; Mulas, G; Nevin, DK; Rossi, D; Sacchetti, G1
Allahtavakoli, M; Arababadi, MK; Javanmardi, K; Moloudi, R; Shamsizadeh, A1
Carta, AR; Pisanu, A1
Bowen, KK; Feinstein, DL; Kapadia, R; Liang, J; Satriotomo, I; Tureyen, K; Vemuganti, R1

Reviews

1 review(s) available for rosiglitazone and Brain Inflammation

ArticleYear
Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?
    Neurotoxicity research, 2013, Volume: 23, Issue:2

    Topics: Animals; Antiparkinson Agents; Encephalitis; Humans; Microglia; Parkinson Disease; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones

2013

Other Studies

5 other study(ies) available for rosiglitazone and Brain Inflammation

ArticleYear
Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.
    Journal of neuroinflammation, 2017, Sep-08, Volume: 14, Issue:1

    Topics: AIDS Dementia Complex; Animals; Encephalitis; HIV-1; Male; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones

2017
N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone.
    Stroke, 2013, Volume: 44, Issue:12

    Topics: Brain; Encephalitis; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Neutrophils; PPAR gamma; Rosiglitazone; Stroke; Thiazolidinediones

2013
Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice.
    Neuroscience, 2015, 08-27, Volume: 302

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Encephalitis; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Lipopolysaccharides; Male; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; NF-kappa B; Parkinsonian Disorders; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Thiobarbiturates; Tyrosine 3-Monooxygenase

2015
Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Brain research, 2009, May-19, Volume: 1271

    Topics: Animals; Brain Infarction; Brain Ischemia; Cell Death; Disease Models, Animal; DNA Fragmentation; Encephalitis; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Leukocyte Count; Male; Neuroprotective Agents; Neutrophils; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome

2009
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Journal of neurochemistry, 2007, Volume: 101, Issue:1

    Topics: Anilides; Animals; Cerebral Infarction; Chemotaxis, Leukocyte; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Encephalitis; Hypertension; Intercellular Adhesion Molecule-1; Ischemic Attack, Transient; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neuroprotective Agents; Pioglitazone; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Superoxide Dismutase-1; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazolidinediones

2007